Transmembrane Protease Serine 11d
Introduction
The gene TMPRSS11D encodes a protein classified as a transmembrane serine protease. Serine proteases are a diverse family of enzymes characterized by a serine residue within their active site, which is essential for their ability to cleave peptide bonds in other proteins. These proteolytic enzymes play fundamental roles in numerous biological processes, including protein degradation, blood coagulation, fibrinolysis, immune responses, and the remodeling of tissues.. [1] As a transmembrane protein, TMPRSS11D is integrated into cellular membranes, indicating that its enzymatic activity is likely localized to specific cellular compartments or the cell surface, where it can precisely regulate protein processing events.
Clinical Relevance
The broad class of proteases is known to be critical for human health, with imbalances often contributing to various diseases. For instance, CPN1 (arginine carboxypeptidase-1), a liver-expressed plasma metalloprotease, plays a protective role by neutralizing potent vasoactive and inflammatory peptides in the body. [1] Similarly, tissue plasminogen activator (tPA), another protease, is vital for the process of fibrinolysis, which involves the breakdown of blood clots. [2] While these examples highlight the general clinical importance of proteases, specific clinical associations or diseases directly linked to genetic variations within TMPRSS11D are not explicitly detailed in the provided research.
Social Importance
Understanding the function of proteases and their inhibitors is paramount for advancing medical knowledge and developing therapeutic strategies. Research into these enzymes helps elucidate fundamental disease mechanisms and identify potential targets for drug development.. [1] However, the specific societal impacts or direct implications arising from research into TMPRSS11D are not extensively discussed within the available context.
Methodological and Statistical Constraints
Many genome-wide association studies (GWAS) are susceptible to limited statistical power, particularly when attempting to detect genetic effects of modest size. [3] This limitation can lead to false negative findings, where true associations with transmembrane protease serine 11d or its related phenotypes are not detected due to insufficient sample size. Consequently, the observed associations may represent only a fraction of the true genetic influences, potentially underestimating the overall genetic contribution to the trait.
A significant challenge in GWAS is the extensive multiple testing performed, which necessitates stringent statistical correction to control for false positives. [4] Studies that do not fully adjust for multiple comparisons may report inflated p-values, increasing the risk of identifying spurious associations with transmembrane protease serine 11d. [4] Furthermore, early GWAS often utilized only a subset of available SNPs, potentially missing causal variants or genes influencing transmembrane protease serine 11d due to incomplete genomic coverage. [2]
Population Specificity and Phenotypic Assessment
Many foundational GWAS cohorts, such as the Framingham Heart Study, were predominantly composed of individuals of European descent, limiting the direct generalizability of findings to other racial or ethnic groups. [3] Genetic variants influencing transmembrane protease serine 11d may exhibit different frequencies or effect sizes across diverse populations, making it crucial to validate associations in multi-ancestry cohorts. [3] This demographic homogeneity also introduces potential age-related biases, as some cohorts were largely middle-aged to elderly, which might not accurately reflect genetic effects in younger populations or across the entire lifespan. [3]
The precise definition and assessment of phenotypes can significantly impact association study results. For instance, some studies relied on means of repeated observations or twin pairs, which, while reducing measurement error, can complicate the interpretation of effect sizes when scaled to population variance. [4] Additionally, the adjustment for covariates in analyses, while necessary to control for confounding, may inadvertently mask or mediate the true genetic effects of transmembrane protease serine 11d, leading to an incomplete understanding of its biological pathways. [2]
Incomplete Genetic Understanding and Replication Challenges
A persistent limitation in genetic research is the challenge of replicating findings across independent cohorts, which is crucial for validating initial associations. [3] Non-replication can arise from various factors, including true false positives in initial studies, differences in study design or power, or variation in linkage disequilibrium patterns across populations, where different proxy SNPs might be associated with the same causal variant. [5] Such complexities underscore that the identified variants for transmembrane protease serine 11d may not always represent the true causal mutations, necessitating further fine-mapping and functional validation.
Despite significant progress in identifying genetic loci, GWAS typically explain only a fraction of the heritable variation for complex traits, a phenomenon known as "missing heritability." This suggests that many genetic influences on transmembrane protease serine 11d remain undiscovered, potentially involving rare variants, structural variations, or complex epistatic interactions not well-captured by common SNP arrays. [5] Furthermore, the interplay between genetic predispositions and environmental factors, including gene-environment interactions, is often not fully elucidated in current GWAS, representing a substantial knowledge gap in understanding the full etiology of traits related to transmembrane protease serine 11d.
Variants
Variants in genes related to cell signaling, immune response, and protein processing can influence various biological pathways, including those involving transmembrane proteases like TMPRSS11D. The MST1 gene, or Macrophage Stimulating 1, plays a role as a proto-oncogene involved in cell survival, proliferation, and differentiation. It is also recognized for its involvement in immune regulation and inflammatory processes, which are often modulated by proteases. Specific variants such as rs9837520 and rs3197999 within or near MST1 may impact its expression or function, thereby subtly influencing cellular responses and potentially affecting the broader inflammatory milieu where proteases like TMPRSS11D operate. Such genetic variations can contribute to individual differences in immune system activity.
The TMPRSS11D gene encodes a transmembrane serine protease, a class of enzymes critical for numerous physiological functions, including immune responses, tissue remodeling, and the activation of various proteins. As a transmembrane protease, TMPRSS11D is likely involved in cell surface processes, potentially interacting with extracellular proteins or contributing to cellular entry mechanisms. Variants like rs17088693, rs1440743, and rs1371927 are located in genomic regions associated with both TMPRSS11D and UBA6-DT (Ubiquitin Like Modifier Activating Enzyme 6, Divergent Transcript). These variants may influence the expression levels or activity of TMPRSS11D, potentially altering its role in inflammation, host defense, or the processing of specific substrates, thereby impacting related cellular pathways.
Further impacting immune regulation are variants found in the Major Histocompatibility Complex (MHC) region, such as rs143325653, which is associated with the TSBP1-AS1 - HLA-DRA locus. The HLA-DRA gene is fundamental to the adaptive immune system, encoding a component of the MHC class II complex that presents antigens to T-cells, thereby initiating immune responses. Variations in HLA genes are well-known to significantly influence immune system function and susceptibility to a range of autoimmune and inflammatory conditions. The intricate interplay between HLA-mediated antigen presentation and the enzymatic activities of proteases like TMPRSS11D, which might be involved in antigen processing or the modulation of immune cell surfaces, suggests a potential for overlapping traits and coordinated genetic influences on immune health.
Other variants contribute to broader cellular functions that can indirectly affect the activity and environment of proteases. The IP6K1 gene, encoding Inositol Polyphosphate Multikinase 1, is involved in inositol phosphate metabolism, a critical pathway for cell signaling, metabolic regulation, and gene expression. The variant rs11716895 associated with IP6K1 may modulate these fundamental cellular processes. Similarly, the RAB44 gene, part of the RAS oncogene family, encodes a small GTPase essential for intracellular vesicle trafficking and transport. The variant rs236448, located in the RAB44 - GPR166P (G Protein-Coupled Receptor 166, Pseudogene) region, could affect cellular transport mechanisms. Disruptions in these core cellular functions, whether in signaling or trafficking, can impact the synthesis, localization, or regulatory environment of proteases like TMPRSS11D, indirectly influencing their overall physiological roles.
There is no information about 'transmembrane protease serine 11d' in the provided context. Therefore, a biological background section cannot be generated.
There is no information about 'transmembrane protease serine 11d' in the provided context.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs9837520 rs3197999 |
MST1 | social interaction measurement level of alpha-hemoglobin-stabilizing protein in blood transmembrane protease serine 11d measurement educational attainment |
| rs17088693 | UBA6-DT, TMPRSS11D | transmembrane protease serine 11d measurement |
| rs1440743 | UBA6-DT | transmembrane protease serine 11d measurement |
| rs1371927 | TMPRSS11D, UBA6-DT | transmembrane protease serine 11d measurement |
| rs143325653 | TSBP1-AS1 - HLA-DRA | susceptibility to plantar warts measurement susceptibility to scarlet fever measurement transmembrane protease serine 11d measurement level of interleukin-12 subunit beta in blood |
| rs11716895 | IP6K1 | blood protein amount transmembrane protease serine 11d measurement |
| rs236448 | RAB44 - GPR166P | transmembrane protease serine 11d measurement |
References
[1] Yuan, X., et al. "Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes." Am J Hum Genet, 2008.
[2] Yang, Q., et al. "Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study." BMC Med Genet, vol. 8, no. Suppl 1, 2007, p. S12.
[3] Benjamin, E. J., et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S9. PMID: 17903293.
[4] Benyamin, B., et al. "Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels." Am J Hum Genet, vol. 84, no. 1, 2009, pp. 60-5. PMID: 19084217.
[5] Sabatti, C., et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nat Genet, vol. 41, no. 1, 2009, pp. 35-42. PMID: 19060910.